Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study

Research output: Contribution to journalReviewResearchpeer-review

  1. The prevalence of EBV and CMV DNA in epithelial ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Use of antidepressants and endometrial-cancer risk: a nationwide nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Survival in Women Diagnosed With Breast Cancer During Pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Patricia Swai
  • Vibeke Rasch
  • Ditte S Linde
  • Bariki Mchome
  • Rachel Manongi
  • Chun Sen Wu
  • Marianne Waldstrom
  • Thomas Iftner
  • Julius Mwaiselage
  • Susanne K Kjaer
View graph of relations

BACKGROUND: High-risk (HR) human papillomavirus (HPV) persistence is the most important risk factor for cervical cancer. We have assessed the type-specific HR HPV persistence among HIV positive and HIV negative Tanzanian women and factors associated with HR HPV persistence.

METHODS: In a cohort study including 4080 Tanzanian women, 3074 attended follow-up examination (up to 32 months after enrollment). Cervical samples were obtained for liquid-based cytology and HPV DNA testing using Hybrid Capture 2 and Inno-Lipa Extra II. Information on lifestyle factors was collected through a personal interview. The probability of HR HPV persistence at a given time point since enrollment was estimated non-parametrically using the EMICM algorithm.

RESULTS: Among the 462 women HR HPV positive at enrollment, 158 had at least one identical type detected at follow-up. The probability of persistence at 18 months after enrollment was 34.2 (95% CI 29.0-39.4). Stratifying by HIV status, the persistence probability was 42.9% (95% CI 33.5-51.9) among HIV positive, and 28.0% (95% CI 22.1-34.2) among HIV negative. Overall, HR HPV persistence was most common for HPV58, 35, 16, 31, and 52. Among HIV positive women it was HPV45, and HPV16, followed by HPV58 and HPV18, and among HIV negative women it was HPV31, HPV33 and HPV58. Risk factors associated with persistence of HR HPV were older age, longer interval between enrollment and follow-up, binge drinking, and HIV status.

CONCLUSIONS: HR HPV persistence was common in Tanzania, and most common among HIV positive women. Overall, persistence was most frequent for HPV 58, 35, 16, 31 and 52. The nonavalent HPV vaccine should be considered.

Original languageEnglish
Article number26
JournalInfectious Agents and Cancer
Volume17
Issue number1
Pages (from-to)26
ISSN1750-9378
DOIs
Publication statusPublished - 11 Jun 2022

Bibliographical note

© 2022. The Author(s).

ID: 78740655